Literature DB >> 31195851

Considering the spleen in sickle cell disease.

Sara El Hoss1,2,3, Valentine Brousse1,2,3,4.   

Abstract

Introduction: In human physiology, the spleen is generally neglected, and its role is considered anecdotal. In sickle cell disease, splenic dysfunction is the main cause of life-threatening complications, particularly in early childhood with the risk of pneumococcal overwhelming sepsis and acute splenic sequestration crisis, notably. During the course of the disease, the spleen functionally declines and anatomically disappears, albeit with great individual variability depending on modulating genetic and environmental factors. Areas covered: The present review aims to provide an overview of spleen structure and function in order to highlight its role in sickling disorders. The clinical features of spleen damage in sickle cell disease, as well as complications and short- and long-term consequences, are reviewed, along with the main therapeutic options. Expert opinion: Management of acute splenic sequestration recurrence and timing of splenectomy in children with sickling disorders are two main areas in which clinical studies are needed.

Entities:  

Keywords:  Spleen; acute splenic sequestration; children; infectious risk; sickle cell disease

Mesh:

Year:  2019        PMID: 31195851     DOI: 10.1080/17474086.2019.1627192

Source DB:  PubMed          Journal:  Expert Rev Hematol        ISSN: 1747-4094            Impact factor:   2.929


  7 in total

1.  Retention of functional mitochondria in mature red blood cells from patients with sickle cell disease.

Authors:  Chiara Moriconi; Monika Dzieciatkowska; Micaela Roy; Angelo D'Alessandro; Philippe Roingeard; June Young Lee; David R Gibb; Maria Tredicine; Marlon A McGill; Annie Qiu; Francesca La Carpia; Richard O Francis; Eldad A Hod; Tiffany Thomas; Martin Picard; Imo J Akpan; Chance John Luckey; James C Zimring; Steven L Spitalnik; Krystalyn E Hudson
Journal:  Br J Haematol       Date:  2022-06-07       Impact factor: 8.615

2.  In-Depth Immunological Typization of Children with Sickle Cell Disease: A Preliminary Insight into Its Plausible Correlation with Clinical Course and Hydroxyurea Therapy.

Authors:  Giulia Giulietti; Daniele Zama; Francesca Conti; Mattia Moratti; Maria Teresa Presutti; Tamara Belotti; Maria Elena Cantarini; Elena Facchini; Mirna Bassi; Paola Selva; Elisabetta Magrini; Marcello Lanari; Andrea Pession
Journal:  J Clin Med       Date:  2022-05-27       Impact factor: 4.964

Review 3.  Splenomegaly in Children and Adolescents.

Authors:  Meinolf Suttorp; Carl Friedrich Classen
Journal:  Front Pediatr       Date:  2021-07-09       Impact factor: 3.418

4.  Serum Immunoglobulin Levels in Children with Sickle Cell Disease: A Large Prospective Study.

Authors:  Sophia Cherif-Alami; Isabelle Hau; Cécile Arnaud; Annie Kamdem; Basil Coulon; Elodie Idoux; Stéphane Bechet; Rita Creidy; Françoise Bernaudin; Ralph Epaud; Corinne Pondarré
Journal:  J Clin Med       Date:  2019-10-15       Impact factor: 4.241

5.  The protective effect of the spleen in sickle cell patients. A comparative study between patients with asplenia/hyposplenism and hypersplenism.

Authors:  Sari Peretz; Leonid Livshits; Etheresia Pretorius; Asya Makhro; Anna Bogdanova; Max Gassmann; Ariel Koren; Carina Levin
Journal:  Front Physiol       Date:  2022-08-29       Impact factor: 4.755

6.  Splenectomy perspective for non-malignant hematological disorders: A cross-sectional study in the Eastern Province of KSA.

Authors:  Mortadah H Alsalman; Faisal A Al Jabr; Samma T Eraqe; Sayed I Ali; Abdallah Essa
Journal:  J Taibah Univ Med Sci       Date:  2022-03-08

7.  Sickle cell disease and malaria: decreased exposure and asplenia can modulate the risk from Plasmodium falciparum.

Authors:  Richard O Mwaiswelo; William Mawala; Per O Iversen; Mariane de Montalembert; Lucio Luzzatto; Julie Makani
Journal:  Malar J       Date:  2020-04-25       Impact factor: 2.979

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.